David Hopkiss
Founder
Welcome to AlveoGene, a pioneering leader in healthcare innovation. We are revolutionizing rare respiratory disease treatment with cutting-edge Orally Inhaled Gene Therapy. Our breakthrough technology aims to transform outcomes by directly addressing the genetic root causes.
At AlveoGene, we’re driven by the vision of a future where patients can breathe freely and live life to the fullest. With a relentless commitment to research and development, we’re shaping a new paradigm in healthcare. Join us in our mission to empower patients and families, as we work tirelessly to create a world where respiratory diseases are no longer a barrier to vibrant living.
